Proteasome inhibition drastically but reversibly impairs murine lymphocyte development.

Maseda D, Meister S, Neubert K, Herrmann M, Voll RE
Cell Death Differ. 2008 15 (3): 600-12

PMID: 18188168 · DOI:10.1038/sj.cdd.4402297

The proteasome inhibitor bortezomib, which induces cell death in various cancer cell lines including lymphatic neoplasias, has recently been approved for the treatment of relapsed multiple myeloma. Important mechanisms of proteasome inhibitor-mediated tumor cell death are the inhibition of NF-kappaB activation and induction of the terminal unfolded protein response (UPR). However, little is known about effects of bortezomib on developing and mature lymphocytes. Therefore, Balb/C mice were injected with bortezomib and lymphocyte subsets were analyzed. This treatment resulted in dramatically decreased numbers of T and B lymphocyte precursors, while mature lymphocytes were only partially affected. Thymocytes were almost depleted 3 days after a single bortezomib injection, pro-B and pre-B cells already after 2 days. Thymocytes and B cell precursors recovered within 2 weeks. The decreased numbers of developing lymphocytes were due to apoptotic cell death accompanied by strongly increased caspase 3/7 activity. Within 8 h after bortezomib injection, there was a strong induction of heat shock protein 70 and C/EBP homologous protein in bone marrow B cells, indicating endoplasmic reticulum stress and activation of the terminal UPR, respectively. Hence, induction of apoptosis by proteasome inhibition can dramatically affect lymphocyte development, a fact which has important implications for the clinical use of bortezomib, especially in situations with ongoing lymphopoiesis.

MeSH Terms (21)

Animals Apoptosis B-Lymphocyte Subsets Bone Marrow Cells Boronic Acids Bortezomib Cells, Cultured Female Lymphocyte Count Lymphoid Tissue Mice Mice, Inbred BALB C NF-kappa B Precursor Cells, B-Lymphoid Precursor Cells, T-Lymphoid Protease Inhibitors Proteasome Inhibitors Protein Folding Pyrazines T-Lymphocyte Subsets Thymus Gland

Connections (1)

This publication is referenced by other Labnodes entities: